122 related articles for article (PubMed ID: 22956574)
21. Cardiac reverse remodelling by imaging parameters with recent changes to guideline medical therapy in heart failure.
Kodsi M; Makarious D; Gan GCH; Choudhary P; Thomas L
ESC Heart Fail; 2023 Dec; 10(6):3258-3275. PubMed ID: 37871982
[TBL] [Abstract][Full Text] [Related]
22. Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
Aimo A; Vergaro G; González A; Barison A; Lupón J; Delgado V; Richards AM; de Boer RA; Thum T; Arfsten H; Hülsmann M; Falcao-Pires I; Díez J; Foo RSY; Chan MYY; Anene-Nzelu CG; Abdelhamid M; Adamopoulos S; Anker SD; Belenkov Y; Ben Gal T; Cohen-Solal A; Böhm M; Chioncel O; Jankowska EA; Gustafsson F; Hill L; Jaarsma T; Januzzi JL; Jhund P; Lopatin Y; Lund LH; Metra M; Milicic D; Moura B; Mueller C; Mullens W; Núñez J; Piepoli MF; Rakisheva A; Ristić AD; Rossignol P; Savarese G; Tocchetti CG; van Linthout S; Volterrani M; Seferovic P; Rosano G; Coats AJS; Emdin M; Bayes-Genis A
Eur J Heart Fail; 2022 Jun; 24(6):944-958. PubMed ID: 35488811
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney disease.
Fuchs MA; Burke EJ; Latic N; Murray S; Li H; Sparks M; Abraham D; Zhang H; Rosenberg P; Hänzelmann S; Hausmann F; Huber T; Erben R; Fisher-Wellman K; Bursac N; Wolf M; Grabner A
Res Sq; 2023 Dec; ():. PubMed ID: 38196615
[TBL] [Abstract][Full Text] [Related]
24. Assessment of Pulmonary Hypertension in Chronic Kidney Disease Patients using Doppler Echocardiography.
Gaur J; Singh RK; Kulkarni C; Dube S
Heart Views; 2023; 24(1):24-28. PubMed ID: 37124428
[TBL] [Abstract][Full Text] [Related]
25. T Cells Play a Causal Role in Diastolic Dysfunction during Uremic Cardiomyopathy.
Winterberg PD; Robertson JM; Kelleman MS; George RP; Ford ML
J Am Soc Nephrol; 2019 Mar; 30(3):407-420. PubMed ID: 30728178
[TBL] [Abstract][Full Text] [Related]
26. Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
González A; Richards AM; de Boer RA; Thum T; Arfsten H; Hülsmann M; Falcao-Pires I; Díez J; Foo RSY; Chan MY; Aimo A; Anene-Nzelu CG; Abdelhamid M; Adamopoulos S; Anker SD; Belenkov Y; Ben Gal T; Cohen-Solal A; Böhm M; Chioncel O; Delgado V; Emdin M; Jankowska EA; Gustafsson F; Hill L; Jaarsma T; Januzzi JL; Jhund PS; Lopatin Y; Lund LH; Metra M; Milicic D; Moura B; Mueller C; Mullens W; Núñez J; Piepoli MF; Rakisheva A; Ristić AD; Rossignol P; Savarese G; Tocchetti CG; Van Linthout S; Volterrani M; Seferovic P; Rosano G; Coats AJS; Bayés-Genís A
Eur J Heart Fail; 2022 Jun; 24(6):927-943. PubMed ID: 35334137
[TBL] [Abstract][Full Text] [Related]
27. Mapping cardiac remodeling in chronic kidney disease.
Kaesler N; Cheng M; Nagai J; O'Sullivan J; Peisker F; Bindels EMJ; Babler A; Moellmann J; Droste P; Franciosa G; Dugourd A; Saez-Rodriguez J; Neuss S; Lehrke M; Boor P; Goettsch C; Olsen JV; Speer T; Lu TS; Lim K; Floege J; Denby L; Costa I; Kramann R
Sci Adv; 2023 Nov; 9(47):eadj4846. PubMed ID: 38000021
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function.
Falcão-Pires I; Ferreira AF; Trindade F; Bertrand L; Ciccarelli M; Visco V; Dawson D; Hamdani N; Van Laake LW; Lezoualc'h F; Linke WA; Lunde IG; Rainer PP; Abdellatif M; Van der Velden J; Cosentino N; Paldino A; Pompilio G; Zacchigna S; Heymans S; Thum T; Tocchetti CG
Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38837573
[TBL] [Abstract][Full Text] [Related]
29. An unusual concomitance of acute heart failure: prolactinoma in a patient with left ventricular dysfunction-a case report.
Saito W; Idouji M; Shibue K; Ito S
Eur Heart J Case Rep; 2023 Nov; 7(11):ytad487. PubMed ID: 37954559
[TBL] [Abstract][Full Text] [Related]
30. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology.
Junho CVC; Frisch J; Soppert J; Wollenhaupt J; Noels H
Clin Kidney J; 2023 Nov; 16(11):1786-1803. PubMed ID: 37915935
[TBL] [Abstract][Full Text] [Related]
31. The role of cardiac remodeling associated with renal function in mediating cardiovascular event outcomes.
Lv Z; Fu Y; Liu C; Ma Y; Yuan M; Ren J; Gao D
iScience; 2024 Mar; 27(3):109143. PubMed ID: 38384844
[TBL] [Abstract][Full Text] [Related]
32. Insights into uremic cardiomyopathy and cardiac remodeling following kidney transplantation: A call for further research.
Floria M; Floria DE; Tănase DM
Int J Cardiol; 2024 Jun; 404():131960. PubMed ID: 38499251
[No Abstract] [Full Text] [Related]
33. Adverse cardiac remodelling: discerning the normal from the pathologic using ethnic-specific echocardiographic thresholds.
Vidula MK; Chirinos JA
Eur Heart J Cardiovasc Imaging; 2022 Jan; 23(2):175-176. PubMed ID: 34792126
[No Abstract] [Full Text] [Related]
34. Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR-Dependent FAK/AKT Signaling Activation.
Zheng X; Liu L; Liu J; Zhang C; Zhang J; Qi Y; Xie L; Zhang C; Yao G; Bu P
Adv Sci (Weinh); 2023 Aug; 10(24):e2207631. PubMed ID: 37344348
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and complications of fracture in older adults with chronic kidney disease: a cross-sectional study.
Meng Y; Fu M; Guo J; Wang Z; Zhang Y; Hou Z
J Orthop Surg Res; 2022 Aug; 17(1):377. PubMed ID: 35933366
[TBL] [Abstract][Full Text] [Related]
36. Renal function in patients with significant tricuspid regurgitation: pathophysiological mechanisms and prognostic implications.
Butcher SC; Fortuni F; Dietz MF; Prihadi EA; van der Bijl P; Ajmone Marsan N; Bax JJ; Delgado V
J Intern Med; 2021 Sep; 290(3):715-727. PubMed ID: 34114700
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve Surgery.
Moskowitz G; Hong KN; Giustino G; Gillinov AM; Ailawadi G; DeRose JJ; Iribarne A; Moskowitz AJ; Gelijns AC; Egorova NN
J Am Coll Cardiol; 2019 Nov; 74(21):2607-2620. PubMed ID: 31753204
[TBL] [Abstract][Full Text] [Related]
38. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
Czaya B; Faul C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
[TBL] [Abstract][Full Text] [Related]
39. Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
Zeitler EP; Friedman DJ; Daubert JP; Al-Khatib SM; Solomon SD; Biton Y; McNitt S; Zareba W; Moss AJ; Kutyifa V
J Am Coll Cardiol; 2017 May; 69(19):2369-2379. PubMed ID: 28494974
[TBL] [Abstract][Full Text] [Related]
40. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.
Chatterjee NA; Borgquist R; Chang Y; Lewey J; Jackson VA; Singh JP; Metlay JP; Lindvall C
Eur Heart J; 2017 May; 38(19):1485-1494. PubMed ID: 28065904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
